Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

RSS icon
Late-breaking cardiovascular study presentation at AHA 2022. #AHA22

VIDEO: Key takeaways from AHA 2022

Manesh R. Patel, MD, chair of AHA Scientific Sessions program, explains what he saw as the top takeaways from AHA 2022.

November 10, 2022
While a vast majority of heart transplants in the United States are successful, unplanned hospitalizations after the procedures are still incredibly common. Top 10 reasons for readmission after heart transplant.

Bypass surgery the best way to limit amputations, death among CLTI patients

Researchers examined data from more than 1,800 CLTI patients, comparing bypass surgery with minimally invasive treatment options such as angioplasty and stenting.

November 7, 2022
Medtronic’s IN.PACT Admiral DCBs

Drug-coated balloons an effective tool in the battle against femoropopliteal disease

Two late-breaking clinical trials presented at the VIVA Foundation’s VIVA22 conference in Las Vegas highlighted the impact drug-coated balloons can make on patient outcomes. 

November 4, 2022
A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare. Sex differences in TAVR one-year mortality.

Predictors of 1-year mortality after TAVR are significantly different among men and women

Atrial fibrillation and peripheral artery disease, for example, are both predictors of mortality among women, but not men. 

November 3, 2022
Intravascular lithotripsy (IVL) therapy to break up calcified coronary lesions will now be reimbursed at a higher rate under new in-hospital codes the went into effect Oct. 1. Illustration of the Shockwave lithoplasty procedure using sonic waves to bust calcium without trauma.

Late-breaking study examines IVL’s safety and effectiveness among real-life PAD patients

The new study, based on data from nearly 1,400 PAD patients who were treated with Shockwave Medical's IVL technology, was presented at VIVA22 in Las Vegas. 

November 2, 2022
The American College of Cardiology (ACC) has published a new guidance document focused on the treatment of patients who present with atherosclerotic cardiovascular disease (ASCVD) and other chronic conditions sch as hypertension, diabetes and atrial fibrillation (AFib).

American College of Cardiology shares expert analysis on treating ASCVD patients with multiple chronic conditions

The new guidance document was designed to help cardiologists and other clinicians deliver the best care possible when treating ASCVD patients who present with additional conditions that need to be considered. 

October 26, 2022
In-hospital complications are more common among women who undergo LAAO than men. However, according to a new study in JACC: Cardiovascular Interventions, men and women have similar long-term outcomes.

LAAO equally effective for men and women, new long-term study confirms

In-hospital complications are more common among women who undergo LAAO than men. However, according to a new study in JACC: Cardiovascular Interventions, men and women have similar long-term outcomes.

October 21, 2022
Doctor patient with masks

COVID-19 drug Paxlovid may react poorly with certain heart medications, cardiologists warn

Nirmatrelvir-ritonavir, sold by Pfizer under the name Paxlovid, is commonly prescribed to treat COVID-19. When treating some heart patients, however, physicians may want to consider an alternative approach.

October 19, 2022
Displaying 145 - 152 of 741
Design by Adaptive Theme